Handelsbanken Fonder Ab Exact Sciences Corp Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 48,600 shares of EXAS stock, worth $2.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,600

Previous 39,200 23.98%

Holding current value

$2.75 Million

Previous $1.66 Million 99.94%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$42.43 - $70.83 $398,842 - $665,802	9,400 Added 23.98%	48,600 $3.31 Million
Q2 2024 Aug 05, 2024	BUY	$41.33 - $74.26 $33,064 - $59,408	800 Added 2.08%	39,200 $1.66 Million
Q1 2024 May 13, 2024	BUY	$56.27 - $73.77 $236,334 - $309,834	4,200 Added 12.28%	38,400 $2.65 Million
Q4 2023 Feb 01, 2024	BUY	$59.06 - $75.72 $17,718 - $22,716	300 Added 0.88%	34,200 $2.53 Million
Q3 2023 Oct 19, 2023	BUY	$65.94 - $99.04 $276,948 - $415,968	4,200 Added 14.14%	33,900 $2.31 Million
Q2 2023 Aug 02, 2023	BUY	$62.68 - $95.05 $31,340 - $47,525	500 Added 1.71%	29,700 $2.79 Million
Q1 2023 Apr 28, 2023	BUY	$47.19 - $70.77 $198,198 - $297,234	4,200 Added 16.8%	29,200 $1.98 Million
Q4 2022 Feb 07, 2023	BUY	$30.35 - $53.15 $247,200 - $432,906	8,145 Added 48.32%	25,000 $1.24 Million
Q2 2022 Aug 03, 2022	SELL	$35.61 - $76.23 $1.53 Million - $3.28 Million	-42,971 Reduced 71.83%	16,855 $664,000
Q1 2022 May 11, 2022	BUY	$57.56 - $82.54 $252,112 - $361,525	4,380 Added 7.9%	59,826 $4.18 Million
Q4 2021 Feb 08, 2022	SELL	$72.5 - $100.68 $15.6 Million - $21.6 Million	-214,817 Reduced 79.48%	55,446 $4.32 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $2.71 Million - $3.72 Million	30,000 Added 12.49%	270,263 $25.8 Million
Q2 2021 Aug 03, 2021	BUY	$93.66 - $139.27 $1.06 Million - $1.57 Million	11,268 Added 4.92%	240,263 $29.9 Million
Q1 2021 Apr 29, 2021	SELL	$116.57 - $155.01 $2.76 Million - $3.67 Million	-23,700 Reduced 9.38%	228,995 $30.2 Million
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $5.98 Million - $8.53 Million	-60,000 Reduced 19.19%	252,695 $33.5 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $9.9 Million - $13.8 Million	-135,700 Reduced 30.26%	312,695 $31.9 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $923,666 - $1.54 Million	-16,568 Reduced 3.56%	448,395 $39 Million
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $2.5 Million - $6.89 Million	66,013 Added 16.55%	464,963 $27 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $11.4 Million - $14.7 Million	146,950 Added 58.31%	398,950 $36.9 Million
Q3 2019 Oct 31, 2019	BUY	$90.37 - $122.49 $5.6 Million - $7.59 Million	62,000 Added 32.63%	252,000 $22.8 Million
Q2 2019 Jul 12, 2019	BUY	$89.51 - $118.04 $2.69 Million - $3.54 Million	30,000 Added 18.75%	190,000 $22.4 Million
Q1 2019 May 10, 2019	SELL	$61.98 - $96.5 $3.66 Million - $5.7 Million	-59,100 Reduced 26.97%	160,000 $13.9 Million
Q4 2018 Jan 31, 2019	SELL	$56.04 - $82.66 $498,756 - $735,674	-8,900 Reduced 3.9%	219,100 $13.8 Million
Q3 2018 Oct 19, 2018	BUY	$48.29 - $80.6 $724,350 - $1.21 Million	15,000 Added 7.04%	228,000 $18 Million
Q2 2018 Jul 11, 2018	SELL	$37.84 - $69.96 $340,560 - $629,640	-9,000 Reduced 4.05%	213,000 $12.7 Million
Q1 2018 May 18, 2018	BUY	$39.82 - $57.53 $2.99 Million - $4.31 Million	75,000 Added 51.02%	222,000 $8.95 Million
Q4 2017 Feb 21, 2018	BUY	$46.49 - $60.51 $6.83 Million - $8.89 Million	147,000 New	147,000 $7.72 Million
Q4 2017 Feb 08, 2018	SELL	$46.49 - $60.51 $7.58 Million - $9.86 Million	-163,000 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$37.05 - $47.12 $6.04 Million - $7.68 Million	163,000	163,000 $7.68 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Exact Sciences Corp Transaction History